Results 171 to 180 of about 16,846 (200)

UBE2O as a key regulator of drug-induced erythropoiesis in the context of myelodysplastic syndromes. [PDF]

Blood Adv
Maffeo B, Panuzzo C, Savi A, Itri F, Piccioli S, Danzero AC, Maglione A, Marini S, Voso MT, Fava C, Bracco E, Pergolizzi B, Cilloni D.   +12 more
europepmc   +1 more source

What's new in hematopathology 2025: myeloid neoplasms in the WHO 5th edition and ICC. [PDF]

J Pathol Transl Med
Aqil B.
europepmc   +1 more source

Early genetic evolution of driver mutations in uveal melanoma. [PDF]

Nat Commun
Dollar JJ, Decatur CL, Weis E, Schefler AC, Materin MA, Fuller TS, Skalet AH, Reichstein DA, Kim IK, Piggott KD, Demirci H, Aaberg TA, Mruthyunjaya P, Williams BK, Shildkrot E, Oliver SCN, Char DH, Capone A, Mason JO, Walter SD, Altaweel MM, Wells JR, Gombos DS, Duker JS, Hovland PG, Tsai T, Javid C, Durante MA, Covington KR, Zhang S, Correa ZM, Harbour JW.   +31 more
europepmc   +1 more source

Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes. [PDF]

Blood Res
Lee WH, Lin CC, Tsai XC, Hsu CL, Yao CY, Tien FM, Lo MY, Chang YS, Kuo YY, Yu SC, Liu MC, Yuan CT, Tseng MH, Peng YL, Yao M, Ko BS, Tien HF, Hou HA, Chou WC.   +18 more
europepmc   +1 more source

MDS/MPN With SF3B1 Mutation and Thrombocytosis but Without Ring Sideroblasts. [PDF]

Am J Hematol
Hazarika B, Bain BJ.
europepmc   +1 more source

Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohort. [PDF]

J Hematop
Patwardhan PP, Al Amri RD, Baloda V, Aarabi M, Aggarwal N, Djokic M, Monaghan SA, Moore EM, Rea B, Bailey NG.   +9 more
europepmc   +1 more source

Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis. [PDF]

Ann Hematol
Huang L, Shi X, Tang N, Liu J, Liang Y, Wang X.   +5 more
europepmc   +1 more source

Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts. [PDF]

Front Oncol
Wang Y, Jin S.
europepmc   +1 more source

SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway. [PDF]

JCI Insight
Zhang B, Iyer P, Jin M, Hacken ET, Cartun ZJ, Hart KL, Fernandez M, Stevenson K, Rassenti L, Ghia EM, Kipps TJ, Neuberg D, Carrasco R, Chan WC, Song JY, Hu Y, Wu CJ, Wang L.   +17 more
europepmc   +1 more source

Beyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms. [PDF]

Transl Vis Sci Technol
Dankberg A, Yu G, Rodriguez FJ.
europepmc   +1 more source